Država: Izrael
Jezik: engleski
Izvor: Ministry of Health
PRAVASTATIN SODIUM
UNIPHARM LTD, ISRAEL
C10AA03
TABLETS
PRAVASTATIN SODIUM 10 MG
PER OS
Required
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL
PRAVASTATIN
PRAVASTATIN
Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet and other nonpharmacological measures alone has been inadequate. Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease pravastatin is indicated to: 1) Reduce the risk of myocardial infarcton. 2) Reduce the risk for revascularization. 3) Reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes. Secondary prevention of cardiovascular events: a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease including prior MI pravastatin is indicated to: 1)Slow the progression of coronary atherosclerosis. 2) Reduce the risk of acute coronary events. b) Myocardial infarction: in patients with previous
2010-03-31
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS )PREPARATIONS( – 1986 The medicine is dispensed with a doctor’s prescription only PRAVALIP 10; 20; 40 TABLETS COMPOSITION: Each PRAVALIP 10 tablet contains: Pravastatin sodium 10 mg Each PRAVALIP 20 tablet contains: Pravastatin sodium 20 mg Each PRAVALIP 40 tablet contains: Pravastatin sodium 40 mg For the list of inactive ingredients, please see section 6. READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. This medicine has been prescribed to treat your ailment. Do not pass it on to others. It may harm them, even if it seems to you that their ailment is similar. This medicine is not intended for use in children and adolescents under 18 years of age. THERAPEUTIC GROUP: Pravastatin belongs to a group of medicines called “statins”. Statins inhibit the activity of the HMG-CoA reductase enzyme. 1. WHAT IS THE MEDICINE INTENDED FOR? Reduction of cholesterol, LDL-C and triglyceride levels, and increase in HDL-C levels. In hypercholesterolemic patients and with no evidence of coronary disease, pravastatin reduces the risk of myocardial infarction and extends the life expectancy. In patients with atherosclerosis and average )normal( or high cholesterol level, pravastatin reduces the risk of overall mortality and of mortality due to heart diseases, and reduces the risk of heart attack; in hypercholesterolemic patients, pravastatin reduces the risk of angina pectoris. 2. BEFORE USING THE MEDICINE DO NOT USE THE PREPARATION IF: • you are pregnant, planning to become pregnant or are breastfeeding. • you are sensitive )allergic( to pravastatin or to any of the additional ingredients contained in the medicine )listed in section 6(. • you are suffering from active liver disease or from unexplained, persistent elevations in liver function test results. 119108010 03D20 SPECIAL WARNINGS REGARDING USE Pročitajte cijeli dokument